獅子山集團(01127.HK):2022年純利2.2億港元 同比增長66%
格隆匯3月31日丨獅子山集團(01127.HK)發佈公吿,截至2022年12月31日止年度,收益為24.96億港元,同比增長43.7%;公司股東應占盈利為2.2億港元,同比增長66%;基本每股盈利29.70港仙,擬派末期股息每股0.07港元及特別股息每股0.03港元。
期內收益增長是由於自2022年4月起計入The Quarto Group, Inc.的業績所致,其為新增的書籍出版分部貢獻約8.759億港元的收益。印刷分部所產生的外部營業額減少約1.174億港元。該減少是由於Quarto成為集團附屬公司後不再計入來自Quarto的印刷收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.